<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR44">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cook</surname>
    <given-names>RL</given-names>
   </name>
   <name>
    <surname>Weber</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>Mai</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Thoma</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Hu</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Brumback</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Karki</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Bryant</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Rathore</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Young</surname>
    <given-names>M</given-names>
   </name>
  </person-group>
  <article-title>Acceptability and feasibility of a randomized clinical trial of oral naltrexone vs. placebo for women living with HIV infection: study design challenges and pilot study results</article-title>
  <source>Contemp Clin Trials</source>
  <year>2017</year>
  <volume>60</volume>
  <fpage>72</fpage>
  <lpage>77</lpage>
  <pub-id pub-id-type="doi">10.1016/j.cct.2017.06.012</pub-id>
  <?supplied-pmid 28642209?>
  <pub-id pub-id-type="pmid">28642209</pub-id>
 </element-citation>
</ref>
